This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2247161 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-01 November 12, 2024.

The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.

Project Description:

The NIH, NIAID, Vaccine Research Center (VRC), Vaccine Production Program (VPP), has a current requirement for brand-name Piccolo Express Chemistry Analyzers.  These analyzers are needed for the post discharge study in the L9LS clinical trials which are being run in  Kenya.  It is only important to ensure that the Piccolo Xpress instrument, which are considered simple and low-risk, and are regulated by the Clinical Laboratory Improvement Amendments (CLIA). Very importantly, the new instruments must match current instruments  used to perform on earlier study. Due to continuity protocols, as well as compatibility, the requested analyzer brand is required. Currently we have 1 Piccolo in the BSL2 and 4 in the BSL4. The Piccolo Xpress is a portable analyzer that has a small footprint and produces accurate, reliable, and reproducible results. The requested brand is required due to

continuity, compatibility, size requirements. This equipment will allow for continued analysis of samples and in order to maintain continuity in research

The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center, Vaccine Production Program (VPP) has a requirement for the following Brand Name Supplies:

Description of need:

1. Chemistry Analyzer – Piccolo Xpress Analyzer, Part # 07P05-01, Qty - 2
2. Shipping & Handling, Qty - 1

Delivery:  45 days ARO

Place of Performance: NIH, NIAID, VRC, VPP, 9 West Watkins Mill Road, Gaithersburg, MD  20878, United States.  FOB: Destination

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: technical capability to meet the requirements, price, and delivery.

By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation

(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NO